Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Vellas

Showing results (71-80 of 436) with videos related to

Pageof 44
Sort By:
Nestle Nutrition Workshop Series. Clinical & Performance Programme|August 9, 2001
Comprehensive geriatric assessment (CGA) and the MNA: an overview of CGA, nutritional assessment, and development of a shortened version of the MNAL Z Rubenstein, J Harker, Y Guigoz, et al.
Age and Ageing|July 1, 1994
A two-centre, randomized, double-blind trial of ornithine oxoglutarate in 194 elderly, ambulatory, convalescent subjectsP Brocker, B Vellas, J L Albarede, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 1, 1989
[Psychological factors in falls in elderly patients]J L Albarède, A Lemieux, B Vellas, et al.
Revue Neurologique|December 3, 2014
Amyloid beta peptide immunotherapy in Alzheimer diseaseJ Delrieu, P J Ousset, T Voisin, et al.
The Journal of Nutrition, Health & Aging|March 26, 2005
Long-term cholinergic treatment is not associated with greater risk of weight loss during Alzheimer's disease: data from the French REAL.FR cohortS Gillette-Guyonnet, F Cortes, C Cantet, et al.
The Journal of Prevention of Alzheimer'S Disease|December 21, 2017
Journal of Prevention of Alzheimer's Disease (JPAD): Building a "Fleet" Against Alzheimer's DiseaseB Vellas, J Touchon, P Aisen, et al.
Metabolism: Clinical and Experimental|February 19, 2026
Corrigendum to "Current and investigational medications for the treatment of sarcopenia" [Metabolism 2023;149:155597]Y Rolland, C Dray, B Vellas, et al.
Current Medical Research and Opinion|July 4, 2002
Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezilS Auriacombe, J J Pere, Y Loria-Kanza, et al.
The Journal of Nutrition, Health & Aging|April 14, 2012
Frailty and agingS Sourdet, M E Rougé-Bugat, B Vellas, et al.
The Journal of Nutrition, Health & Aging|January 27, 2011
Progress in the development of new drugs in Alzheimer's diseaseAntoine Piau, F Nourhashémi, C Hein, et al.
Pageof 44

Showing results (71-80 of 436) with videos related to

Sort By:
Pageof 44
Nestle Nutrition Workshop Series. Clinical & Performance Programme|August 9, 2001
Comprehensive geriatric assessment (CGA) and the MNA: an overview of CGA, nutritional assessment, and development of a shortened version of the MNAL Z Rubenstein, J Harker, Y Guigoz, et al.
Age and Ageing|July 1, 1994
A two-centre, randomized, double-blind trial of ornithine oxoglutarate in 194 elderly, ambulatory, convalescent subjectsP Brocker, B Vellas, J L Albarede, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 1, 1989
[Psychological factors in falls in elderly patients]J L Albarède, A Lemieux, B Vellas, et al.
Revue Neurologique|December 3, 2014
Amyloid beta peptide immunotherapy in Alzheimer diseaseJ Delrieu, P J Ousset, T Voisin, et al.
The Journal of Nutrition, Health & Aging|March 26, 2005
Long-term cholinergic treatment is not associated with greater risk of weight loss during Alzheimer's disease: data from the French REAL.FR cohortS Gillette-Guyonnet, F Cortes, C Cantet, et al.
The Journal of Prevention of Alzheimer'S Disease|December 21, 2017
Journal of Prevention of Alzheimer's Disease (JPAD): Building a "Fleet" Against Alzheimer's DiseaseB Vellas, J Touchon, P Aisen, et al.
Metabolism: Clinical and Experimental|February 19, 2026
Corrigendum to "Current and investigational medications for the treatment of sarcopenia" [Metabolism 2023;149:155597]Y Rolland, C Dray, B Vellas, et al.
Current Medical Research and Opinion|July 4, 2002
Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezilS Auriacombe, J J Pere, Y Loria-Kanza, et al.
The Journal of Nutrition, Health & Aging|April 14, 2012
Frailty and agingS Sourdet, M E Rougé-Bugat, B Vellas, et al.
The Journal of Nutrition, Health & Aging|January 27, 2011
Progress in the development of new drugs in Alzheimer's diseaseAntoine Piau, F Nourhashémi, C Hein, et al.
Pageof 44